
Carmine Cuda
Examiner (ID: 8210)
| Most Active Art Unit | 3205 |
| Art Unit(s) | 3201, 3205, 2878 |
| Total Applications | 602 |
| Issued Applications | 542 |
| Pending Applications | 0 |
| Abandoned Applications | 60 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 356279
[patent_doc_number] => 07488715
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-02-10
[patent_title] => 'Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/213023
[patent_app_country] => US
[patent_app_date] => 2005-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14158
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/488/07488715.pdf
[firstpage_image] =>[orig_patent_app_number] => 11213023
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/213023 | Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use | Aug 25, 2005 | Issued |
Array
(
[id] => 6978530
[patent_doc_number] => 20050288248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-29
[patent_title] => 'Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/212439
[patent_app_country] => US
[patent_app_date] => 2005-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14133
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0288/20050288248.pdf
[firstpage_image] =>[orig_patent_app_number] => 11212439
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/212439 | Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use | Aug 25, 2005 | Issued |
Array
(
[id] => 5894879
[patent_doc_number] => 20060003418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/213083
[patent_app_country] => US
[patent_app_date] => 2005-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14109
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20060003418.pdf
[firstpage_image] =>[orig_patent_app_number] => 11213083
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/213083 | Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use | Aug 25, 2005 | Abandoned |
Array
(
[id] => 5894878
[patent_doc_number] => 20060003417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/213026
[patent_app_country] => US
[patent_app_date] => 2005-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14110
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20060003417.pdf
[firstpage_image] =>[orig_patent_app_number] => 11213026
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/213026 | Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use | Aug 25, 2005 | Issued |
Array
(
[id] => 5894880
[patent_doc_number] => 20060003419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/213087
[patent_app_country] => US
[patent_app_date] => 2005-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14113
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20060003419.pdf
[firstpage_image] =>[orig_patent_app_number] => 11213087
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/213087 | Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use | Aug 25, 2005 | Issued |
Array
(
[id] => 422031
[patent_doc_number] => 07273963
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-09-25
[patent_title] => 'Malarial animal model having a chimeric human liver'
[patent_app_type] => utility
[patent_app_number] => 11/207176
[patent_app_country] => US
[patent_app_date] => 2005-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15083
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/273/07273963.pdf
[firstpage_image] =>[orig_patent_app_number] => 11207176
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/207176 | Malarial animal model having a chimeric human liver | Aug 16, 2005 | Issued |
Array
(
[id] => 5517083
[patent_doc_number] => 20090217390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'Non-human animal sarcoma model'
[patent_app_type] => utility
[patent_app_number] => 11/919487
[patent_app_country] => US
[patent_app_date] => 2005-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6580
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0217/20090217390.pdf
[firstpage_image] =>[orig_patent_app_number] => 11919487
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/919487 | Non-human animal sarcoma model | Apr 28, 2005 | Abandoned |
Array
(
[id] => 6931730
[patent_doc_number] => 20050282765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Enzyme having S-adenosyl-L-homocysteine hydrolase (AHCY) type activity'
[patent_app_type] => utility
[patent_app_number] => 11/110748
[patent_app_country] => US
[patent_app_date] => 2005-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5456
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20050282765.pdf
[firstpage_image] =>[orig_patent_app_number] => 11110748
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/110748 | Enzyme having S-adenosyl-L-homocysteine hydrolase (AHCY) type activity | Apr 20, 2005 | Abandoned |
Array
(
[id] => 7216476
[patent_doc_number] => 20050260165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-24
[patent_title] => 'HS-40 enhancer-containing vector'
[patent_app_type] => utility
[patent_app_number] => 11/103355
[patent_app_country] => US
[patent_app_date] => 2005-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3583
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20050260165.pdf
[firstpage_image] =>[orig_patent_app_number] => 11103355
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/103355 | HS-40 enhancer-containing vector | Apr 10, 2005 | Abandoned |
Array
(
[id] => 7004652
[patent_doc_number] => 20050169965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'Compounds with improved cartilage-inducing and/or bone-inducing activity'
[patent_app_type] => utility
[patent_app_number] => 11/080494
[patent_app_country] => US
[patent_app_date] => 2005-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5970
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20050169965.pdf
[firstpage_image] =>[orig_patent_app_number] => 11080494
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/080494 | Compounds with improved cartilage-inducing and/or bone-inducing activity | Mar 15, 2005 | Issued |
Array
(
[id] => 809886
[patent_doc_number] => 07416859
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-08-26
[patent_title] => 'Rhodococcus cloning and expression vectors'
[patent_app_type] => utility
[patent_app_number] => 11/069691
[patent_app_country] => US
[patent_app_date] => 2005-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18167
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/416/07416859.pdf
[firstpage_image] =>[orig_patent_app_number] => 11069691
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/069691 | Rhodococcus cloning and expression vectors | Feb 28, 2005 | Issued |
Array
(
[id] => 7185205
[patent_doc_number] => 20050191744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-01
[patent_title] => 'Method for differentiating primate embryonic stem cell into vascular cell'
[patent_app_type] => utility
[patent_app_number] => 11/063584
[patent_app_country] => US
[patent_app_date] => 2005-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9732
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20050191744.pdf
[firstpage_image] =>[orig_patent_app_number] => 11063584
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/063584 | Method for differentiating primate embryonic stem cell into vascular cell | Feb 23, 2005 | Issued |
Array
(
[id] => 5678345
[patent_doc_number] => 20060183701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-17
[patent_title] => 'Methods and compositions for determining non-specific cytotoxicity of a transfection agent'
[patent_app_type] => utility
[patent_app_number] => 11/059209
[patent_app_country] => US
[patent_app_date] => 2005-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17808
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20060183701.pdf
[firstpage_image] =>[orig_patent_app_number] => 11059209
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/059209 | Methods and compositions for determining non-specific cytotoxicity of a transfection agent | Feb 14, 2005 | Abandoned |
Array
(
[id] => 5769433
[patent_doc_number] => 20050265978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-01
[patent_title] => 'Muscle-derived cells (MDCs) for treating muscle- or bone-related injury or dysfunction'
[patent_app_type] => utility
[patent_app_number] => 11/040900
[patent_app_country] => US
[patent_app_date] => 2005-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 33312
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0265/20050265978.pdf
[firstpage_image] =>[orig_patent_app_number] => 11040900
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/040900 | Muscle-derived cells (MDCs) for treating muscle- or bone-related injury or dysfunction | Jan 20, 2005 | Issued |
Array
(
[id] => 123663
[patent_doc_number] => 07705197
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-27
[patent_title] => 'Embryo development and survival'
[patent_app_type] => utility
[patent_app_number] => 11/039662
[patent_app_country] => US
[patent_app_date] => 2005-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6299
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/705/07705197.pdf
[firstpage_image] =>[orig_patent_app_number] => 11039662
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/039662 | Embryo development and survival | Jan 18, 2005 | Issued |
Array
(
[id] => 8386412
[patent_doc_number] => 08263821
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-11
[patent_title] => 'Non-invasive real-time in vivo bioluminescence imaging of local CaÂ2+ dynamics in living organisms'
[patent_app_type] => utility
[patent_app_number] => 11/032236
[patent_app_country] => US
[patent_app_date] => 2005-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 30
[patent_no_of_words] => 19013
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11032236
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/032236 | Non-invasive real-time in vivo bioluminescence imaging of local CaÂ2+ dynamics in living organisms | Jan 10, 2005 | Issued |
Array
(
[id] => 7977235
[patent_doc_number] => 08071364
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-06
[patent_title] => 'Gene therapy using transposon-based vectors'
[patent_app_type] => utility
[patent_app_number] => 10/583812
[patent_app_country] => US
[patent_app_date] => 2004-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 33281
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/071/08071364.pdf
[firstpage_image] =>[orig_patent_app_number] => 10583812
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/583812 | Gene therapy using transposon-based vectors | Dec 23, 2004 | Issued |
Array
(
[id] => 6968874
[patent_doc_number] => 20050235367
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Regulatory sequences capable of conferring expression of a heterologous DNA sequence in endothelial cells and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/015329
[patent_app_country] => US
[patent_app_date] => 2004-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 18985
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20050235367.pdf
[firstpage_image] =>[orig_patent_app_number] => 11015329
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/015329 | Regulatory sequences capable of conferring expression of a heterologous DNA sequence in endothelial cells and uses thereof | Dec 16, 2004 | Abandoned |
Array
(
[id] => 7136619
[patent_doc_number] => 20050181395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-18
[patent_title] => 'Systems for tightly regulated gene expression'
[patent_app_type] => utility
[patent_app_number] => 11/010599
[patent_app_country] => US
[patent_app_date] => 2004-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 58
[patent_figures_cnt] => 58
[patent_no_of_words] => 8741
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20050181395.pdf
[firstpage_image] =>[orig_patent_app_number] => 11010599
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/010599 | Systems for tightly regulated gene expression | Dec 12, 2004 | Abandoned |
Array
(
[id] => 4684288
[patent_doc_number] => 20080250514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'Expression Systems Using Mammalian Beta-Actin Promoter'
[patent_app_type] => utility
[patent_app_number] => 10/581183
[patent_app_country] => US
[patent_app_date] => 2004-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12411
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20080250514.pdf
[firstpage_image] =>[orig_patent_app_number] => 10581183
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/581183 | Expression systems using mammalian beta-actin promoter | Dec 2, 2004 | Issued |